Humacyte HUMA
NASDAQ HUMA
$0.50 -0.01 (-2.86%)
At close: Oct 1, 2026 · 4:00 PM EDT

Humacyte (HUMA) Price to Book (2021 - 2026)

Updated

Humacyte's (HUMA) Price to Book came in at 6.93 for Q2 2026, down 91.4% from 80.64 a year earlier and down 40.5% from the prior quarter.

Analysis

Humacyte (HUMA) Price to Book (2021 - 2026) Analysis & Trends

For FY2025, Humacyte's Price to Book stood at 48.84.

  • In prior years, Humacyte's Price to Book was 21.74 in FY2023, 1.86 in FY2022 (-21.5%) and 2.37 in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Price to Book since Q2 2023.
  • The strongest year-over-year quarter for Price to Book in the past five years was Q1 2024, with growth of 263.2%; the weakest was Q2 2026, with a decline of 91.4%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Humacyte 144.46 Mn 144.46 Mn -825,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.93
Mar 31, 2026 11.65
Dec 31, 2025 48.84
Jun 30, 2025 80.64
Mar 31, 2025 7.36
Mar 31, 2024 14.16
Dec 31, 2023 21.74
Sep 30, 2023 8.19
Jun 30, 2023 4.84
Mar 31, 2023 3.90
Dec 31, 2022 1.86
Sep 30, 2022 2.83
Jun 30, 2022 2.32
Mar 31, 2022 7.00
Dec 31, 2021 2.37
Sep 30, 2021 6.73
API Access

Humacyte Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=HUMA&period=max&api_key=YOUR_API_KEY